Clinical Study
Comparison the Efficacy of Fluconazole and Terbinafine in Patients with Moderate to Severe Seborrheic Dermatitis
Table 4
Comparison of itching in three-phase study.
| | Drugs | (%) | (%) | (%) | (%) | Mean itching ± SD | | Without itching | Mild itching | Moderate itching | Severe itching |
| Before treatment | Fluconazole (28) | 0 (0%) | 15 (53.6%) | 6 (21.4%) | 7 (25%) | 1.71 ± 0.85 | 0.459 | Terbinafine (32) | 4 (12.5%) | 7 (21.9%) |
11 (34.4%) | 10 (31.2%) | 1.84 ± 1.019 |
| After treatment | Fluconazole (28) | 15 (53.6%) | 10 (35.7%) | 3 (10.7%) | 0 (0%) |
0.57 ± 0.69 | 0.220 | Terbinafine (32) | 15 (46.9%) | 6 (18.8%) | 11 (34.4%) | 0 (0%) | 0. 87 ± 0.90 |
| Two weeks after treatment | Fluconazole (28) | 16 (57.1%) | 9 (32.1%) | 3 (10.7%) | 0 (0%) | 0. 53 ± 0.69 | 0.773 | Terbinafine (32) | 18 (56.2%) | 14 (43.8%) | 0 (0%) | 0 (0%) | 0. 43 ± 0.50 |
|
|
*Mann-Whitney test.
|